Common symptoms of renal pelvis cancer?

summary

The appearance of renal pelvis cancer has seriously affected the physical and mental health of patients, making many patients suffer from pain. In the late stage, life is worse than death. In principle, radical nephrectomy should be performed for renal pelvic tumors, but organ sparing surgery can also be used for single tumors with lower stage and grade. Surgery is still the main treatment for pyelocarcinoma. Resection of the diseased kidney and the whole ureter, including the partial bladder near the ureteral orifice, can prevent the recurrence of residual ureteral tumor. Common symptoms of renal pelvis cancer? Let's have a look.

Common symptoms of renal pelvis cancer?

30-50% of patients with transitional cell carcinoma of the renal pelvis may also have transitional cell carcinoma of the bladder at the same time. The main symptom is hematuria. Hematuria occurred in almost all patients, of which about 85% were the first symptom, most of them were gross hematuria, but microscopic hematuria often appeared before gross hematuria, the early stage of the disease. The characteristic of gross hematuria is painless, mostly the whole course hematuria.

Renal cancer patients in the early performance may appear hematuria, about 70% of renal cancer patients will appear hematuria. This kind of hematuria is often intermittent, may also stop itself, but will repeatedly attack. If we can pay attention to the first hematuria and seek medical treatment as soon as possible, we can get early diagnosis.

This kind of disease is mainly transitional cell carcinoma, and a few are squamous cell carcinoma and adenocarcinoma. Squamous cell carcinoma and adenocarcinoma account for about 15% of renal pelvis carcinoma, and their malignant degree is far higher than that of transitional cell carcinoma. Transitional cell carcinoma can appear successively or simultaneously in any urinary tract covered with transitional epithelium. Therefore, the diagnosis and treatment of transitional cell carcinoma should be considered as a whole.

matters needing attention

The 5-year survival rate of radical operation and non radical operation was 84% and 51%, respectively. However, whether regional lymphadenectomy should be performed in radical operation has not been unified. The 5-year survival rates of G1, G2 and G3 were 75%, 55% and 27%, respectively; The prognosis of squamous cell carcinoma and adenocarcinoma was poor, and the 5-year survival rate was 0.